Ciclopirox Nail Lacquer DTC Ads Should Be Avoided - FDA Advisory Cmte.
Executive Summary
Direct-to-consumer advertising of Hoechst Marion Roussel's ciclopirox nail lacquer treatment for onychomycosis should be avoided because of the narrow population for which the drug is effective, FDA's Dermatologic & Ophthalmic Drugs Advisory Committee said Nov. 4.